Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1386 per EA under NDC 62135061812. Its NADAC has been published 202 times since Oct 12, 2022.
FDA first approved this application on Oct 21, 2020. Its Orange Book therapeutic-equivalence code is AA.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET
Diphenoxylate hydrochloride and atropine sulfateStrength
.025; 2.5 mg/1; mg/1
Manufacturer
Chartwell RX LLCNDC
62135061812
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207128FDA Approved
10/21/2020
TE Code
AA
On Market Since
10/21/2020
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 202 times since Oct 12, 2022, and over the history we have for it it has declined 35.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1386 per EA |
|---|---|
| All-time high | $0.2446 (Apr 10, 2024) |
| All-time low | $0.1298 (Nov 20, 2024) |
| 52-week high | $0.1837 |
| 52-week low | $0.1371 |
| Median price | $0.1772 |
| Average price | $0.1769 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 202 |
| Tracking since | Oct 12, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diphenoxylate hydrochloride and atropine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by Chartwell RX LLC, is $0.1386 per EA (NDC 62135061812), effective Aug 19, 2026.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has declined 35.3%. It has been tracked across 202 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
Since Oct 12, 2022, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1298 (Nov 20, 2024) to a high of $0.2446 (Apr 10, 2024), with a median of $0.1772 per EA.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 62135061812) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.